B · Normal On September 3rd, Morgan Stanley raised Kelun Pharmaceutical's rating to overweight, with a target price of 61 yuan. 🕐 2026-09-03 16:16 🖼️ Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇ Share 🔗Copy Link 📘Facebook 🐦X (Twitter) 💬WhatsApp 💼LinkedIn 👽Reddit ← Back to Telegraph
Comments